BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 2990350)

  • 1. [Clinical trial of MCNU for malignant brain tumors].
    Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of intra-arterial and local administration of MCNU on cerebral malignant gliomas].
    Watanabe M; Takeda N; Tanaka R
    Gan To Kagaku Ryoho; 1995 May; 22(6):811-4. PubMed ID: 7755390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of ACNU alone and combined with tegafur as additions to radiotherapy of the treatment of malignant gliomas--a cooperative clinical trial].
    Ushio Y; Abe H; Suzuki J; Tanaka R; Kitamura K; Miwa T; Matsutani M; Takeuchi K; Takakura K; Nomura K
    No To Shinkei; 1985 Oct; 37(10):999-1006. PubMed ID: 3000412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MCNU delivery into malignant brain tumor and normal brain tissue by intravenous or intraarterial infusion].
    Miyagami M; Tazoe M; Tsubokawa T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):275-80. PubMed ID: 2154161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinical evaluation of combination therapy with radiation, MCNU, carboplatin and IFN-beta or with radiation, MCNU, carboplatin, etoposide and IFN-beta for malignant gliomas].
    Mizumatsu S; Matsumoto K; Maeda Y; Tamiya T; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2055-60. PubMed ID: 9838907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intratumoral pharmacokinetics following intraarterial administration of MCNU in patients with malignant gliomas].
    Yamasaki T; Nagao S; Kagawa T; Konishi S; Akiyama Y; Fukuda M; Kimura Y; Moritake K
    No Shinkei Geka; 1995 Nov; 23(11):963-9. PubMed ID: 7477717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized study of initial treatment with radiation.MCNU or radiation.MCNU.interferon-beta for malignant glioma. Hiroshima Brain Tumor Study Group].
    Kiya K; Uozumi T; Kurisu K; Inagawa T; Ohta M; Kajikawa H; Kawashima K; Kitaoka T; Goishi A; Kodama Y
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):221-6. PubMed ID: 2405777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of MCNU on brain tumors. Part II: Clinical experience with MCNU on malignant brain tumors].
    Wakabayashi T; Yoshida J; Kito A; Inoue I; Kobayashi T; Kageyama N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2729-37. PubMed ID: 6095764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gliomas in adults: primary non-surgical treatment].
    Poulsen HS
    Ugeskr Laeger; 2006 Nov; 168(47):4082-5. PubMed ID: 17134603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemoradiation for malignant brain tumors].
    Matsutani M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2042-8. PubMed ID: 9388512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
    Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of mustoforan in management of malignant glioma].
    Kobiakov GL
    Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
    Tonn JC; Schönmayr R; Kraemer HP
    J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
    Kobayashi S; Takakura K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on three patients with malignant glioma showing tumor reduction during maintenance therapy with MCNU].
    Kiya K; Uozumi T; Kurisu K; Mikami T; Sugiyama K; Monden S; Maeda H; Matsuoka T; Matsuda Y; Harada K
    Gan To Kagaku Ryoho; 1993 Jun; 20(8):1083-6. PubMed ID: 8512339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemical modifiers in radiotherapy].
    Nagashima T; Takakura K
    Gan No Rinsho; 1989 Sep; 35(11):1369-71. PubMed ID: 2681875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
    Shinohara C; Matsumoto K; Kuriyama M; Adachi H; Ono Y; Higashi H; Furuta T; Ohmoto T
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined treatment of glyal and metastatic tumors of the brain].
    Fadeev BP; Zhabina RM
    Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.